Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
The modifier effect of the BDNF gene in the phenotype of the WAGRO syndrome.
[aniridia]
Individuals
who
are
carriers
of
deletions
of
various
sizes
that
cause
haploinsufficiency
in
the
contiguous
WT
1
and
PAX
6
genes
,
located
on
chromosome
11
p
13
approximately
4
Mb
centromeric
to
the
BDNF
gene
,
are
susceptible
to
Wilms
tumor
,
aniridia
,
mental
retardation
,
genitourinary
anomalies
and
obesity
(
WAGRO
syndrome
)
.
The
molecular
characterization
of
the
wide
deletion
11
p
15
.
1
p
12
arr
(
18676926
-
36576388
)
x
1
dn
in
a
child
with
3
years
and
4
months
of
age
only
affected
by
aniridia
,
predicts
not
only
other
serious
associated
diseases
,
but
also
allows
us
to
hypothesize
a
specific
phenotype
of
mental
impairment
,
conduct
alterations
and
childhood
obesity
,
possibly
added
to
the
onset
of
metabolic
alterations
.
The
variable
appearance
and
/
or
description
of
haploinsufficiency
for
obesity
susceptibility
in
the
WAGR
syndrome
mainly
depends
on
the
critical
region
located
within
80
kb
of
exon
1
of
BDNF
.
The
relationship
between
genetic
variation
based
on
the
genotype
combinations
of
the
4
gene
SNPs
tagging
the
BDNF
gene
and
the
body
mass
index
(
BMI
)
was
studied
.
The
polymorphic
variability
was
similarly
distributed
in
218
children
suffering
a
severe
and
non-syndromic
obesity
from
families
at
high
risk
for
obesity
,
as
compared
with
198
controls
.
The
corroborated
role
of
the
BDNF
gene
as
highly
susceptible
to
severe
syndromic
obesity
has
not
already
been
evidenced
in
the
molecular
basis
of
overweight
attributed
to
the
common
polygenic
principles
.
Its
potential
role
as
risk
modifier
variant
to
provoke
more
severe
phenotype
has
not
yet
been
demonstrated
.
Some
genetic
variants
of
brain-derived
neurotrophic
factor
(
BDNF
)
have
resulted
in
important
disorders
of
energy
balance
,
but
it
is
essential
to
know
exactly
their
deleterious
human
capacity
because
they
play
a
fundamental
role
in
the
development
and
plasticity
of
the
central
nervous
system
in
regulating
food
intake
.
The
existence
of
polymorphic
amino
acid
changes
of
unknown
functional
significance
in
patients
carrying
the
haploinsufficiency
of
the
BDNF
gene
could
constitute
an
adequate
model
to
study
in
depth
their
effects
.
Diseases
Validation
Diseases presenting
"deleterious human capacity"
symptom
aniridia
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom